Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: May Letter to Shareholders from Patriot Scientific President and CEO Rick Goerne
Pretty clear.
While all licensees to date have chosen lump sum front-end buy-outs
However, they do not call J3 licensees. So whatever arrangement we have with them is not yet known. Steve got a hint from his question maybe. Judge Ward overseeing is another clue.
Wonder how long his is going to be our CEO.
Share
New Message
Please login to post a reply